Other health services
LYNX PHARMA AS
Operating profit
NOK −51,000
Equity
NOK −573,000
Incorporated
2023
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.29
Equity ratio
-242.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -21.6% | |
| Likviditet | ||
| Current ratio | 0.29 | |
| Working capital | −573k | |
| Soliditet | ||
| Equity ratio (%%) | -242.2% | |
| Debt-to-equity ratio | -1.41 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.